Volume 6 Number 8 August 2005
This issue contains a report from Gareth Hardy from the Keystone Vaccine Workshop held earlier this year, and the first of a two-part article on HIV and HCV coinfection by Leighton Davies. Both these articles are longer than much of our usual coverage and follow earlier special reports on LGV in the UK, and on HPV vaccines, and we hope these are useful for readers.
This issue of HTB went to press as the IAS International was coming to a close. We have included weblinks to the conference sites and other sites that provide early coverage for readers who want to follow the programme now. Otherwise our coverage from this meeting will be included in the next issue of HTB.
Much of the conference focused on access and prevention-related issues which are also covered in this issue – including an alarming attack on a peaceful demonstration by HIV-positive people in South Africa.
Included as a supplement for this issue of HTB is a report from a meeting held earlier this year, between community treatment advocates and four Indian generic pharmaceutical companies. As well as focusing on manufacturing and pricing issues, the report highlights the different realities relating treatment for HIV-positive people in different parts of the world.